A detailed history of Bell Investment Advisors, Inc transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Bell Investment Advisors, Inc holds 121 shares of CORT stock, worth $6,031. This represents 0.0% of its overall portfolio holdings.

Number of Shares
121
Previous 121 -0.0%
Holding current value
$6,031
Previous $3,000 66.67%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$22.21 - $34.48 $1,110 - $1,723
50 Added 70.42%
121 $3,000
Q1 2023

May 10, 2023

BUY
$19.2 - $24.47 $441 - $562
23 Added 47.92%
71 $1,000
Q4 2022

Feb 08, 2023

BUY
$19.95 - $29.96 $19 - $29
1 Added 2.13%
48 $0
Q2 2022

Aug 12, 2022

SELL
$17.33 - $25.3 $17 - $25
-1 Reduced 2.08%
47 $1,000
Q4 2021

Feb 14, 2022

SELL
$17.1 - $23.34 $342 - $466
-20 Reduced 29.41%
48 $1,000
Q3 2021

Nov 12, 2021

BUY
$19.68 - $22.53 $1,338 - $1,532
68 New
68 $1,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $5.34B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Bell Investment Advisors, Inc Portfolio

Follow Bell Investment Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bell Investment Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bell Investment Advisors, Inc with notifications on news.